Related Experiment Video
Updated: May 16, 2025

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Augmented Acyl-CoA Biosynthesis Promotes Resistance to TEAD Palmitoylation Site Inhibition
Kayla Nutsch1, Marissa N Trujillo2, Lirui Song3
1Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037-1000, United States.
Abstract:
Activation of the YAP-TEAD transcriptional complex drives the growth of several cancer types and is a key resistance mechanism to targeted therapies. Accordingly, a host of pharmacological inhibitors to TEAD family paralogs have been developed, yet little is known as to the resistance mechanisms that might arise against this emerging therapeutic class. Here, we report that genetic augmentation of de novo coenzyme A biosynthesis desensitizes YAP-dependent cancer cells to treatment with TEAD inhibitors, an effect driven by increased levels of palmitoyl-CoA that outcompete drug for engagement of the lipid-binding pocket. This work uncovers a potential therapeutic resistance mechanism to TEAD palmitoylation site inhibition with implications for future combinatorial treatments in the clinic.
Insights
Cancer cells become resistant to TEAD inhibitors when coenzyme A biosynthesis is enhanced. Increased palmitoyl-CoA levels outcompete drugs, revealing a new resistance mechanism against YAP-TEAD targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The YAP-TEAD transcriptional complex promotes cancer growth and resistance to targeted therapies.
- TEAD inhibitors are emerging therapeutics, but their resistance mechanisms are poorly understood.
Purpose of the Study:
- To investigate potential resistance mechanisms against TEAD inhibitors.
- To explore the role of coenzyme A biosynthesis in YAP-dependent cancer cell response to TEAD inhibition.
Main Methods:
- Genetic augmentation of de novo coenzyme A biosynthesis in YAP-dependent cancer cells.
- Assessment of cancer cell sensitivity to TEAD inhibitors.
- Analysis of palmitoyl-CoA levels and drug-target engagement.
Main Results:
- Enhanced de novo coenzyme A biosynthesis desensitizes YAP-dependent cancer cells to TEAD inhibitors.
- Increased palmitoyl-CoA levels were observed, which compete with TEAD inhibitors for binding.
- This suggests a novel resistance mechanism involving lipid metabolism.
Conclusions:
- Augmenting coenzyme A biosynthesis confers resistance to TEAD inhibitors by increasing palmitoyl-CoA.
- This finding uncovers a resistance mechanism to TEAD palmitoylation site inhibition.
- Implications for developing future combinatorial treatments in clinical settings.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Tail-anchoring of Proteins in the ER Membrane
Feedback Inhibition

